|4Feb 22, 2:24 PM ET

Wong Hing C 4

4 · HCW Biologics Inc. · Filed Feb 22, 2024

Insider Transaction Report

Form 4
Period: 2024-02-20
Wong Hing C
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Common Stock

    2024-02-20$1.40/sh+739,288$1,035,00316,054,156 total
Footnotes (1)
  • [F1]The reporting person purchased these shares directly from the issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION